The global discourse surrounding psychopharmacology, mental health treatments, and psychoactive substances frequently intersects with questions about drug classifications. As researchers, clinicians, and public health advocates across the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland examine the distinct properties of various chemical agents, a frequent point of […]